Genjiro Miwa
Founder bij PorMedTec Co., Ltd.
Vermogen: 132 994 $ op 31-03-2024
Profiel
Genjiro Miwa is the founder.
He founded PorMedTec Co., Ltd.
in 2017 and holds the title of Director.
He also founded Megakaryon Corp.
in 2011 and held the title of President & Chief Executive Officer.
Mr. Miwa's education history includes an undergraduate degree from the University of Tokyo, which was conferred in 1974.
He also obtained an MBA from Harvard Business School in 1984.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
KYCOM HOLDINGS CO., LTD.
0.63% | 31-03-2023 | 32 000 ( 0.63% ) | 132 994 $ | 31-03-2024 |
Actieve functies van Genjiro Miwa
Bedrijven | Functie | Begin |
---|---|---|
PorMedTec Co., Ltd.
PorMedTec Co., Ltd. BiotechnologyHealth Technology PorMedTec Co., Ltd. is a Japanese company that specializes in the development of medical pigs for organ transplantation and regenerative medicine. The company was founded in 2017 by Genjiro Miwa and is based in Kawasaki, Japan. PorMedTec aims to provide solutions to the overwhelming lack of organ donors by using pigs for organ transplantation and regenerative organs. The company develops and uses high-value pigs developed for medical purposes and supplies products inexpensively and stably. PorMedTec also offers technical services such as custom-made gene modification pigs and cloning pigs as models for developing drugs and treatments. | Founder | 01-01-2017 |
Eerdere bekende functies van Genjiro Miwa
Bedrijven | Functie | Einde |
---|---|---|
Megakaryon Corp.
Megakaryon Corp. Medical/Nursing ServicesHealth Services Megakaryon Corp. operates as an pluripotent stem cells research laboratory. It produce platelets and red blood cells from iPS cell lines, and to develop blood products that do not depend on blood donations. The firm specializes in development of technologies to produce and store induced pluripotent stem cell derived human T cells. Megakaryon was founded by Genjiro Miwa on September 9, 2011 and is headquartered in Kyoto, Japan. | Chief Executive Officer | - |
Opleiding van Genjiro Miwa
University of Tokyo | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Megakaryon Corp.
Megakaryon Corp. Medical/Nursing ServicesHealth Services Megakaryon Corp. operates as an pluripotent stem cells research laboratory. It produce platelets and red blood cells from iPS cell lines, and to develop blood products that do not depend on blood donations. The firm specializes in development of technologies to produce and store induced pluripotent stem cell derived human T cells. Megakaryon was founded by Genjiro Miwa on September 9, 2011 and is headquartered in Kyoto, Japan. | Health Services |
PorMedTec Co., Ltd.
PorMedTec Co., Ltd. BiotechnologyHealth Technology PorMedTec Co., Ltd. is a Japanese company that specializes in the development of medical pigs for organ transplantation and regenerative medicine. The company was founded in 2017 by Genjiro Miwa and is based in Kawasaki, Japan. PorMedTec aims to provide solutions to the overwhelming lack of organ donors by using pigs for organ transplantation and regenerative organs. The company develops and uses high-value pigs developed for medical purposes and supplies products inexpensively and stably. PorMedTec also offers technical services such as custom-made gene modification pigs and cloning pigs as models for developing drugs and treatments. | Health Technology |